Advanced oxidation protein products (AOPP) and high-sensitive C-reactive protein (hs-CRP) in an "atheroma-free model": Down's syndrome

G. Goi; C. Baquero-Herrera; F. Licastro; G. Dogliotti; M. M. Corsi

doi:10.1016/j.ijcard.2005.10.019

Advanced oxidation protein products (AOPP) and high-sensitive C-reactive protein (hs-CRP) in an "atheroma-free model": Down's syndrome

G. Goi, C. Baquero-Herrera, F. Licastro, G. Dogliotti, M. M. Corsi

IRCCS Policlinico San Donato

Research output: Contribution to journal › Article › peer-review

Abstract

Murdoch et al. in 1977 called Down syndrome an "atheroma-free model." In this preliminary study, we investigated advanced oxidation protein products (AOPP) and high-sensitive C-reactive protein (hs-CRP) in 47 age-matched Down syndrome patients and 20 age-matched healthy controls. In these healthy patients, we detected no new biochemical risk factors for atherosclerosis, such as AOPP and hs-CRP, so risks are probably considerably lower.

Original language	English
Pages (from-to)	427-429
Number of pages	3
Journal	International Journal of Cardiology
Volume	113
Issue number	3
DOIs	https://doi.org/10.1016/j.ijcard.2005.10.019
Publication status	Published - Nov 18 2006

Keywords

AOPP-CRP
Atherosclerosis
Down syndrome

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.ijcard.2005.10.019

Fingerprint Dive into the research topics of 'Advanced oxidation protein products (AOPP) and high-sensitive C-reactive protein (hs-CRP) in an "atheroma-free model": Down's syndrome'. Together they form a unique fingerprint.

Cite this

@article{6482219086ed4772aa957212f1d35738,

title = "Advanced oxidation protein products (AOPP) and high-sensitive C-reactive protein (hs-CRP) in an {"}atheroma-free model{"}: Down's syndrome",

abstract = "Murdoch et al. in 1977 called Down syndrome an {"}atheroma-free model.{"} In this preliminary study, we investigated advanced oxidation protein products (AOPP) and high-sensitive C-reactive protein (hs-CRP) in 47 age-matched Down syndrome patients and 20 age-matched healthy controls. In these healthy patients, we detected no new biochemical risk factors for atherosclerosis, such as AOPP and hs-CRP, so risks are probably considerably lower.",

keywords = "AOPP-CRP, Atherosclerosis, Down syndrome",

author = "G. Goi and C. Baquero-Herrera and F. Licastro and G. Dogliotti and Corsi, {M. M.}",

year = "2006",

month = nov,

day = "18",

doi = "10.1016/j.ijcard.2005.10.019",

language = "English",

volume = "113",

pages = "427--429",

journal = "International Journal of Cardiology",

issn = "0167-5273",

publisher = "Elsevier Ireland Ltd",

number = "3",

}

TY - JOUR

T1 - Advanced oxidation protein products (AOPP) and high-sensitive C-reactive protein (hs-CRP) in an "atheroma-free model"

T2 - Down's syndrome

AU - Goi, G.

AU - Baquero-Herrera, C.

AU - Licastro, F.

AU - Dogliotti, G.

AU - Corsi, M. M.

PY - 2006/11/18

Y1 - 2006/11/18

N2 - Murdoch et al. in 1977 called Down syndrome an "atheroma-free model." In this preliminary study, we investigated advanced oxidation protein products (AOPP) and high-sensitive C-reactive protein (hs-CRP) in 47 age-matched Down syndrome patients and 20 age-matched healthy controls. In these healthy patients, we detected no new biochemical risk factors for atherosclerosis, such as AOPP and hs-CRP, so risks are probably considerably lower.

AB - Murdoch et al. in 1977 called Down syndrome an "atheroma-free model." In this preliminary study, we investigated advanced oxidation protein products (AOPP) and high-sensitive C-reactive protein (hs-CRP) in 47 age-matched Down syndrome patients and 20 age-matched healthy controls. In these healthy patients, we detected no new biochemical risk factors for atherosclerosis, such as AOPP and hs-CRP, so risks are probably considerably lower.

KW - AOPP-CRP

KW - Atherosclerosis

KW - Down syndrome

UR - http://www.scopus.com/inward/record.url?scp=33750695725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750695725&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2005.10.019

DO - 10.1016/j.ijcard.2005.10.019

M3 - Article

C2 - 16343667

AN - SCOPUS:33750695725

VL - 113

SP - 427

EP - 429

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 3

ER -